Pdt Partners, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $923 - $1,180	-68 Reduced 0.1%	71,297 $1.12 Million
Q4 2023 Feb 14, 2024	BUY	$10.11 - $16.54 $362,574 - $593,174	35,863 Added 101.02%	71,365 $1.15 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $442,354 - $549,570	35,502 New	35,502 $451,000
Q4 2022 Feb 14, 2023	SELL	$14.85 - $19.04 $1.35 Million - $1.73 Million	-90,870 Reduced 80.15%	22,510 $368,000
Q3 2022 Nov 14, 2022	SELL	$12.38 - $20.23 $811,273 - $1.33 Million	-65,531 Reduced 36.63%	113,380 $2.1 Million
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $395,665 - $607,179	-43,432 Reduced 19.53%	178,911 $2.35 Million
Q1 2022 May 16, 2022	BUY	$6.87 - $11.11 $1.53 Million - $2.47 Million	222,343 New	222,343 $2.06 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.